Disopyramide
- TRADE NAMES: Dimodan; Dirythmin SA; Disonorm; Durbis; Isorythm; Norpace (Pfizer)
- INDICATIONS: Ventricular arrhythmias
- CLASS: Antiarrhythmic, Antiarrhythmic class Ia, Muscarinic antagonist
- HALF-LIFE: 4–10 hours
Acebutolol, Amiodarone, Amisulpride, Amitriptyline, Arsenic, Artemether/Lumefantrine, Astemizole, Atenolol, Bisoprolol, Celiprolol, Ciprofloxacin, Clarithromycin, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Darifenacin, Degarelix, Dronedarone, Droperidol, Enoxacin, Erythromycin, Gatifloxacin, Gliclazide, Glycopyrrolate, Glycopyrronium, Insulin Aspart, Insulin Degludec, Insulin Glargine, Insulin Glulisine, Itraconazole, Ketoconazole, Levomepromazine, Lomefloxacin, Lurasidone, Metformin, Moxifloxacin, Nevirapine, Nilotinib, Norfloxacin, Ofloxacin, Oxprenolol, Oxybutynin, Pimavanserin, Quinine, Quinolones, Ribociclib, Rifapentine, Roxithromycin, Sildenafil, Sotalol, Sparfloxacin, Sulpiride, Tadalafil, Telithromycin, Tiotropium, Trospium, Vandetanib, Vardenafil, Zuclopenthixol
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
